... We Welcome You To The Resverlogix HUB On AGORACOM!

**Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial (now fully enrolled) and Will Soon Begin Phase 2 Kidney Dialysis and Fabry Disease Trials**

Free
AGORACOM NEWS FLASH

BREAKING: Good Life Networks Inc. increases second quarter revenue year over year by 123% to $3,435,835

  • Q2 revenue increased 123% to $3,435,835 from same quarter last year
  • Reported net income of $252,712, compared to a net loss of $353,632 in the same quarter last year
  • “Our year over year revenue growth for the second quarter was exceptional and further supports our projected revenue and earnings objectives for the full fiscal year,” said Jesse Dylan, GLN President and CEO

Glnlogo black 11

Hub On AGORACOM / Read Release

 

Message: Eastern exercised some $0.90 cent warrants

Also interesting is that the shares and warrants Hepalink acquired in July 2015 were subject to a three year lock-up which recently expired (July 21st I think). The strike on those warrants is $2.67 which we only just recently surpassed.

RESVERLOGIX CLOSES $50 MILLION PRIVATE PLACEMENT WITH HEPALINK AND EASTERN CAPITAL

 

Share
New Message
Please login to post a reply